Apocynin alleviates weight gain and obesity‐induced adipose tissue inflammation in high‐fat diet‐fed C57BL /6 mice
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Yea-Jin Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Diet, High-Fat, Obesity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Obesity involves chronic low‐grade inflammation within adipose tissue. Apocynin (APO) is a therapeutic agent for the treatment of inflammatory diseases. Therefore, the present study aimed to investigate whether APO can reduce weight gain and obesity‐induced adipose tissue inflammation. C57BL/6 mice were administered APO or orlistat (Orli) as a positive control with a high‐fat diet (HFD) for 12 weeks. Lipopolysaccharide‐stimulated 3T3‐L1 adipocytes were used for the in vitro study. Our results showed a significantly lower white adipose tissue (WAT) mass index in 10 mg/kg APO‐treated mice than in 20 mg/kg Orli‐treated mice. Moreover, the protein expression of adipose triglyceride lipase, fatty acid synthase, sterol regulatory element‐binding transcription factor 1, and peroxisome proliferator‐activated receptor γ was reversed in the WAT of 10 mg/kg APO‐treated mice. Furthermore, APO reduced the expression of the macrophage marker F4/80, decreased the mRNA levels of tumor necrosis factor‐α and monocyte chemoattractant protein‐1, and increased the mRNA levels of interleukin‐10 in WAT. APO decreased the phosphorylation of c‐Jun N‐terminal kinase, extracellular signal‐regulated kinase, and p65 in vivo and in vitro. Notably, APO had a stronger effect on the amelioration of adipose tissue inflammation than Orli did. Our findings lay the foundation for research on the use of APO as an agent to ameliorate weight gain and obesity‐induced inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
- Department of Rehabilitative Medicine of Korean Medicine and Neuropsychiatry, College of Korean Medicine, Sangji University, Wonju, Gangwon-do, Republic of Korea.
- Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
ORCID-Profile: Hyo-Jin An
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, Y. J., Gil, T. Y., Jin, B. R., Cha, Y. Y., & An, H. J. (2023). Apocynin alleviates weight gain and obesity‐induced adipose tissue inflammation in high‐fat diet‐fed C57BL /6 mice. Phytotherapy Research. https://doi.org/10.1002/ptr.7823
Vancouver
Park YJ, Gil TY, Jin BR, Cha YY, An HJ. Apocynin alleviates weight gain and obesity‐induced adipose tissue inflammation in high‐fat diet‐fed C57BL /6 mice. Phytotherapy Research. 2023. doi:10.1002/ptr.7823
BibTeX
@article{Park2023,
author = {Park, Yea-Jin and Gil, Tae-Young and Jin, Bo-Ram and Cha, Yun-Yeop and An, Hyo-Jin},
title = {Apocynin alleviates weight gain and obesity‐induced adipose tissue inflammation in high‐fat diet‐fed C57BL /6 mice},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7823}
}
EUVIMED